It’s not enough anymore for journalists to be mere watchdogs. Journalism must address subconscious social biases to give readers a fuller picture of what they need to know.
Articles on Opioid crisis
Displaying 41 - 60 of 97 articles
COVID-19 plagues an overtaxed opioid addiction treatment system.
The U.S. suicide rate has been increasing for decades. According to a sociologist who studies suicide, depression is just one factor among many implicated social conditions.
The overdose crisis — coupled with a lack of accessible harm reduction services — represents a growing concern for young queer and trans men who use drugs.
The crisis has made recovery more difficult for those with substance use disorders. The inability to get to support group meetings, stress and illness are just some of the factors.
Pharmacists are well positioned to provide communities with a lifesaving drug.
Aggressive marketing of prescription opioids by pharmaceutical companies provided doctors with scant information about potential harmful effects.
The Trump administration’s budget for healthcare proposes significant cuts to Medicare, Medicaid and the Affordable Care Act.
In 2016, drug misuse was cited as the top concern among New Hampshire voters. What remedies are the Democratic primary contenders putting forward to combat the opioid crisis?
The government has tried to harness a profit-driven drug industry to serve public health before.
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
Opioid overdoses killed 47,000 Americans in 2017 — more than gun violence. Many fewer would have died if they’d been treated with the life-saving drug naloxone, also called Narcan.
Institutions that benefited from donations from benefactors such as Epstein are facing hard questions. In a somewhat similar ethical debate in 1905, a pastor argued for return of a Rockefeller gift.
Previously secret documents and data make it clear that many companies engaged in the distribution of prescription painkillers either skirted or ignored their legal obligations for years.
In an era of rapid technological advance, devastating climate change, increasing inequality and a steadily aging society, health-care leadership development is vital.
The evidence is clear that newborn babies do better when they ‘room-in’ with their opioid-dependent mothers. So why are hospitals across Canada so slow to provide this recognized standard of care?
A policy response focused on reducing prescription opioids will not resolve North America’s opioid crisis. And it is hurting many adults who live with otherwise unbearable chronic pain.
The $270 million settlement may not mean a whole lot if Purdue files for bankruptcy as it’s reportedly considering.
There are limits to what charities can do now about past donors who are accused of morally reprehensible behavior.
OxyContin maker Purdue has reportedly been mulling a bankruptcy filling, just as the first of around 2,000 lawsuits against it prepares to go to trial.
Top contributors
-
Medical Director of Opioid Policy Research, Brandeis University
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Associate Professor of History, University at Buffalo
-
PhD Candidate, School of Population and Public Health, University of British Columbia
-
PhD Candidate, School of Nursing, University of British Columbia
-
Postdoctoral Fellow, Harvard University
-
Director of Translational Institute of Medicine (TIME), Queen's University, Ontario
-
Professor of Law, Indiana University
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Visiting Assistant Professor of Sociology, College of the Holy Cross
-
Professor, Department of Sociology and Anthropology, University of Guelph
-
Co-Director, Opioid Prescribing Engagement Network and Assistant Professor, University of Michigan
-
Director of the Master of Bioethics degree program at the Berman Institute of Bioethics, Johns Hopkins University
-
Vice-Dean, Faculty of Pain Medicine, ANZCA, Flinders University
-
Reader, Psychology and Language Sciences Division, UCL